IR

Cellid Co.,Ltd. leads development of anti-cancer immunotherapy.

Financial Information

80,000 60,000 40,000 20,000 0 -20,000
80,000 60,000 40,000 20,000 0 -20,000

Total assets

80,000 60,000 40,000 20,000 0 -20,000

Total liabilities

80,000 60,000 40,000 20,000 0 -20,000

Total capitals

80,000 60,000 40,000 20,000 0 -20,000

Operating profit

Balance sheet (unit : 1 million won)Scroll left and right to read.

Item . . .

Income statement (unit : 1 million won)Scroll left and right to read.

Item . . .